MONOGENIC OBESITY
Clinical trials for MONOGENIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new MONOGENIC OBESITY trials appear
Sign up with your email to follow new studies for MONOGENIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot helps teens with rare obesity lose weight
Disease control Recruiting nowThis study looks at whether a once-weekly injection of semaglutide, along with diet and exercise, helps teenagers with monogenic obesity lose weight. About 70 teens aged 12 to 20 will take part for 68 weeks. The main goal is to see if at least 10% of their body mass index (BMI) i…
Matched conditions: MONOGENIC OBESITY
Sponsor: Prof. Dr. Martin Wabitsch • Aim: Disease control
Last updated May 26, 2026 09:56 UTC
-
New drug targets rare obesity gene – hope for uncontrollable hunger
Disease control Recruiting nowThis study tests an experimental drug called mibavademab in people with a rare type of obesity caused by a faulty leptin gene. The gene change stops the body from feeling full, leading to severe weight gain. The drug aims to replace the missing signal and help control weight. Onl…
Matched conditions: MONOGENIC OBESITY
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:53 UTC